Surfacer System to Facilitate Access in Venous Occlusions

NCT02875899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-01-26

No results posted yet for this study

Summary

Prospective, single-arm, multicentre, international Registry of the Surfacer System for the treatment of patients with limited or diminishing upper body venous access or pathology impeding standard access methods.The purpose of this post-market Registry is to assess the standard of care and clinical outcomes of the Surfacer System used in clinical routine according to the approved commercial indications.

Conditions

  • Chronic Venous Thrombosis
  • Venous Thrombosis Upper Extremity
  • Venous Thrombosis Upper Extremity Superficial Veins

Sponsors & Collaborators

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Laura Minarsch, RT · Bluegrass Vascular

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-07
Primary Completion
2018-09-20
Completion
2018-10-04

Countries

  • Austria
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875899 on ClinicalTrials.gov